Combination of Helicobacter Pylori Antibody and Serum Pepsinogen As a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study

Overview

Journal J Epidemiol

Specialty Public Health

Date 2016 Jun 7

PMID 27265836

Citations 37

Authors

Fumie Ikeda

Kentaro Shikata

Jun Hata

Masayo Fukuhara

Yoichiro Hirakawa

Tomoyuki Ohara

Naoko Mukai

Masaharu Nagata

Daigo Yoshida

Koji Yonemoto

Motohiro Esaki

Takanari Kitazono

Yutaka Kiyohara

Toshiharu Ninomiya

Affiliations

Soon will be listed here.

Abstract

Background: There is little information regarding whether the combination of Helicobacter pylori (H. pylori) antibody and serum pepsinogen (sPG), which is a marker of the degree of atrophic gastritis, has a discriminatory ability for detecting incident gastric cancer. We examined this issue in a long-term prospective cohort study of a Japanese population.

Methods: A total of 2446 Japanese community-dwelling individuals aged ≥40 years were stratified into four groups according to baseline H. pylori serological status and sPG: Group A (H. pylori[-], sPG[-]), Group B (H. pylori[+], sPG[-]), Group C (H. pylori[+], sPG[+]), and Group D (H. pylori[-], sPG[+]), and participants were followed up prospectively for 20 years.

Results: During the follow-up, 123 subjects developed gastric cancer. Compared with that in Group A, the cumulative incidence of gastric cancer was significantly increased in Groups B, C, and D, whereas no significant difference was found between Groups C and D. The multivariable-adjusted risk of gastric cancer was significantly increased in Group B (hazard ratio [HR], 4.08; 95% confidence interval [CI], 1.62-10.28) and in Groups C and D combined (HR 11.1; 95% CI, 4.45-27.46). When the multivariable model with H. pylori antibody was changed into that with the combination of H. pylori antibody and sPG, the C statistics for developing gastric cancer increased significantly (0.773 vs 0.732, P = 0.005), and the continuous net reclassification improvement value was 0.591 (P < 0.001).

Conclusions: Our findings suggest that the combination of H. pylori antibody and sPG is a useful tool for predicting the development of gastric cancer.

Citing Articles

Racial/ethnic differences in risk factors for non-cardia gastric cancer: an analysis of the Multiethnic Cohort (MEC) Study.

Adams A, Gandhi A, Friedmann P, Sarkar S, Rana B, Epplein M Cancer Causes Control. 2024; .

PMID: 39509055 DOI: 10.1007/s10552-024-01934-9.

Risk Prediction Models for Gastric Cancer: A Scoping Review.

Xu L, Lyu J, Zheng X, Wang A J Multidiscip Healthc. 2024; 17:4337-4352.

PMID: 39257385 PMC: 11385365. DOI: 10.2147/JMDH.S479699.

Chronic atrophic gastritis and risk of incident upper gastrointestinal cancers: a systematic review and meta-analysis.

Li J, Pan J, Xiao D, Shen N, Wang R, Miao H J Transl Med. 2024; 22(1):429.

PMID: 38711123 PMC: 11075312. DOI: 10.1186/s12967-023-04736-w.

Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancer.

Fu Y, Jiang J, Wu Y, Cao D, Jia Z, Zhang Y Gastric Cancer. 2024; 27(4):735-746.

PMID: 38584223 DOI: 10.1007/s10120-024-01493-7.

Risk Factors for Developing Metachronous Superficial Gastric Epithelial Neoplasms after Endoscopic Submucosal Dissection.

Suzuki T, Goda K, Ishikawa M, Yamaguchi S, Yoshinaga T, Kondo M J Clin Med. 2024; 13(6).

PMID: 38541812 PMC: 10970914. DOI: 10.3390/jcm13061587.

References

Walker I, STRICKLAND R, Ungar B, Mackay I . Simple atrophic gastritis and gastric carcinoma. Gut. 1971; 12(11):906-11. PMC: 1411951. DOI: 10.1136/gut.12.11.906. View

Shikata K, Doi Y, Yonemoto K, Arima H, Ninomiya T, Kubo M . Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol. 2008; 168(12):1409-15. DOI: 10.1093/aje/kwn276. View

Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K . Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama Study. Diabetologia. 1993; 36(11):1198-203. DOI: 10.1007/BF00401066. View

Forman D, Burley V . Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006; 20(4):633-49. DOI: 10.1016/j.bpg.2006.04.008. View

Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H . Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010; 15(1):1-20. DOI: 10.1111/j.1523-5378.2009.00738.x. View

Evans Jr D, Evans D, Graham D, KLEIN P . A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology. 1989; 96(4):1004-8. DOI: 10.1016/0016-5085(89)91616-8. View

Correa P . Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24):6735-40. View

Yamagata H, Kiyohara Y, Aoyagi K, Kato I, Iwamoto H, Nakayama K . Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study. Arch Intern Med. 2000; 160(13):1962-8. DOI: 10.1001/archinte.160.13.1962. View

Miwa H, Kikuchi S, Ohtaka K, Kobayashi O, Ogihara A, Hojo M . Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population. Diagn Microbiol Infect Dis. 2000; 36(2):95-9. DOI: 10.1016/s0732-8893(99)00143-1. View

10.

Hattori Y, Tashiro H, Kawamoto T, Kodama Y . Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens. Jpn J Cancer Res. 1995; 86(12):1210-5. PMC: 5920667. DOI: 10.1111/j.1349-7006.1995.tb03317.x. View

11.

Willett W, Stampfer M . Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986; 124(1):17-27. DOI: 10.1093/oxfordjournals.aje.a114366. View

12.

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

13.

Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y . Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol. 2003; 98(4):735-9. DOI: 10.1111/j.1572-0241.2003.07410.x. View

14.

Miki K . Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2007; 9(4):245-53. DOI: 10.1007/s10120-006-0397-0. View

15.

. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14(2):101-12. DOI: 10.1007/s10120-011-0041-5. View

16.

Pencina M, DAgostino R . Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004; 23(13):2109-23. DOI: 10.1002/sim.1802. View

17.

Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T, Mukoubayashi C . Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis. Int J Cancer. 2012; 131(11):2632-42. DOI: 10.1002/ijc.27514. View

18.

Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T . Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005; 54(6):764-8. PMC: 1774550. DOI: 10.1136/gut.2004.055400. View

19.

Inoue K, Fujisawa T, Haruma K . Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies. Int J Biol Markers. 2010; 25(4):207-12. View

20.

Zhang X, Xue L, Xing L, Wang J, Cui J, Mi J . Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. Int J Cancer. 2011; 130(7):1614-9. DOI: 10.1002/ijc.26172. View